Journal of Neurochemistry 2011-09-01

Expression of the 2',3'-cAMP-adenosine pathway in astrocytes and microglia.

Jonathan D Verrier, Jennifer L Exo, Travis C Jackson, Jin Ren, Delbert G Gillespie, Raghvendra K Dubey, Patrick M Kochanek, Edwin K Jackson

Index: J. Neurochem. 118 , 979-987, (2011)

Full Text: HTML

Abstract

Many organs express the extracellular 3',5'-cAMP-adenosine pathway (conversion of extracellular 3',5'-cAMP to 5'-AMP and 5'-AMP to adenosine). Some organs release 2',3'-cAMP (isomer of 3',5'-cAMP) and convert extracellular 2',3'-cAMP to 2'- and 3'-AMP and convert these AMPs to adenosine (extracellular 2',3'-cAMP-adenosine pathway). As astrocytes and microglia are important participants in the response to brain injury and adenosine is an endogenous neuroprotectant, we investigated whether these extracellular cAMP-adenosine pathways exist in these cell types. 2',3'-, 3',5'-cAMP, 5'-, 3'-, and 2'-AMP were incubated with mouse primary astrocytes or primary microglia for 1 h and purine metabolites were measured in the medium by mass spectrometry. There was little evidence of a 3',5'-cAMP-adenosine pathway in either astrocytes or microglia. In contrast, both cell types converted 2',3'-cAMP to 2'- and 3'-AMP (with 2'-AMP being the predominant product). Although both cell types converted 2'- and 3'-AMP to adenosine, microglia were five- and sevenfold, respectively, more efficient than astrocytes in this regard. Inhibitor studies indicated that the conversion of 2',3'-cAMP to 2'-AMP was mediated by a different ecto-enzyme than that involved in the metabolism of 2',3'-cAMP to 3'-AMP and that although CD73 mediates the conversion of 5'-AMP to adenosine, an alternative ecto-enzyme metabolizes 2'- or 3'-AMP to adenosine.© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.


Related Compounds

  • Adenosine, cyclic2...
  • 1,3-DIPROPYL-8...

Related Articles:

2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.

2011-08-01

[Am. J. Physiol. Heart Circ. Physiol. 301(2) , H391-401, (2011)]

The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.

2012-07-01

[J. Neurochem. 122(1) , 115-25, (2012)]

Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.

2013-01-01

[Am. J. Physiol. Renal Physiol. 304(1) , F49-55, (2013)]

2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.

2011-05-01

[J. Pharmacol. Exp. Ther. 337 , 444-450, (2011)]

2',3'-cAMP hydrolysis by metal-dependent phosphodiesterases containing DHH, EAL, and HD domains is non-specific: Implications for PDE screening.

2010-07-30

[Biochem. Biophys. Res. Commun. 398 , 500-505, (2010)]

More Articles...